15 reports

Grass Pollen Allergy - Pipeline Drugs and Companies, Q## 2019 ##.

  • Digestive System Disorder
  • Pathology

Birch Pollen Allergy - Pipeline Drugs and Companies, Q## 2019 ##.

  • Digestive System Disorder
  • Pathology
  • Therapy

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Digestive System Disorder
  • Monoclonal Antibody
  • United States
  • Product Initiative

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Digestive System Disorder
  • Therapy
  • United States
  • Product Initiative

Increase in Allergy Diseases (Hay Fever) - Allergies are one of the possible reasons for dry eyes.

  • Antifungal
  • Digestive System Disorder
  • Ophthalmology
  • World
  • Forecast

Drug/ Molecule refers to Primary Intervention only. ##.

  • Antifungal
  • Clinical Trial
  • Digestive System Disorder
  • Pharmaceutical
  • World

The drug candidate binds to and inhibits the mRNA of Orai ##, inhibiting the calcium transport.

  • Antifungal
  • Digestive System Disorder
  • Ophthalmology
  • Therapy
  • Aldeyra Therapeutics, Inc.

The drug candidate binds to and inhibits the mRNA of Orai ##, inhibiting the calcium transport.

  • Antifungal
  • Digestive System Disorder
  • Ophthalmology
  • Therapy
  • United States
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Allergy Drug
  • Antifungal
  • Digestive System Disorder
  • Ophthalmology
  • World
  • Clinical Trial profile. 80 Trial Title
  • 5. All the trials included are unique trials.

ALLERGIC CONJUNCTIVITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS ALLERGIC CONJUNCTIVITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* ALLERGIC CONJUNCTIVITIS THERAPEUT

  • Antifungal
  • Ophthalmology
  • Pharmaceutical
  • World
  • Product Initiative

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Digestive System Disorder
  • Monoclonal Antibody
  • Ophthalmology
  • SCYNEXIS, Inc.

Subjects orally took study drug once daily in the evening for one month.

  • Digestive System Disorder
  • Eye Disease
  • Ophthalmology
  • United States
  • Product Initiative

Subjects orally took study drug once daily in the evening for one month.

  • Digestive System Disorder
  • Eye Disease
  • Ophthalmology
  • United States
  • Product Initiative

(allergy and autoimmune diagnostics) which was sold to Thermo Fisher Scientific (TMO) in September of 2011.

  • Ophthalmology
  • Research And Development
  • United States
  • Company
  • ProQR Therapeutics N.V.

The drug candidate is a ##-imino-##, ##, ##-thiadiazole derivative.

  • Digestive System Disorder
  • Ophthalmology
  • Pharmaceutical
  • United States
  • Product Initiative